Login/Sign Up
Suprava TZ 562.5 mg Injection 1's belongs to a class of medication called 'antibiotics' used to treat several bacterial infections of the urinary tract, blood, bones and joints, heart, brain, chest, ears, skin, or soft tissues. A bacterial infection is a condition in which harmful bacteria grow in the body and cause infection. It can infect any part of the body and multiply very quickly. Suprava TZ 562.5 mg Injection 1's does not work against infections caused by the virus.
Suprava TZ 562.5 mg Injection 1's is a combination of two drugs: Ceftriaxone (antibiotic) and Tazobactum (beta-lactamase inhibitor). Ceftriaxone belongs to the class of antibiotics that works by interfering with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damaging the bacterial cell wall and killing bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
You are advised to take Suprava TZ 562.5 mg Injection 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience diarrhea, rash, or abnormalities with white blood cells and platelets. Most of these side effects of Suprava TZ 562.5 mg Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Suprava TZ 562.5 mg Injection 1's, penicillins, or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, please inform your doctor before taking Suprava TZ 562.5 mg Injection 1's. Drive only if you are alert as Suprava TZ 562.5 mg Injection 1's may cause dizziness. You are recommended to complete the full course of Suprava TZ 562.5 mg Injection 1's as prescribed by your doctor for effective results. Suprava TZ 562.5 mg Injection 1's may interact with certain tests such as glucose (sugar) in urine and coomb’s test, giving unusual results. Therefore, inform the doctor that you are taking Suprava TZ 562.5 mg Injection 1's before undergoing any tests.
Suprava TZ 562.5 mg Injection 1's is a combination of two drugs: Ceftriaxone (antibiotic) and Tazobactum (beta-lactamase inhibitor) used to treat several bacterial infections. Ceftriaxone is a broad-spectrum antibiotic that acts against both aerobic (grow in the presence of oxygen) and anaerobic (grow in the absence of oxygen) gram-negative and gram-positive bacteria. It interferes with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damages the bacterial cell wall and kills bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
If you are allergic to Suprava TZ 562.5 mg Injection 1's, penicillins, or any other medicines, please tell your doctor. If you have kidney or liver problems, diarrhea, hemolytic anemia (reduction in red blood cells that may make your skin pale yellow and cause breathlessness or weakness), kidney or gall stones, or inflammation of the large intestine, inform your doctor before taking Suprava TZ 562.5 mg Injection 1's. If you are pregnant or breastfeeding, please inform your doctor before taking Suprava TZ 562.5 mg Injection 1's. Drive only if you are alert as Suprava TZ 562.5 mg Injection 1's may cause dizziness. You are recommended to complete the full course of Suprava TZ 562.5 mg Injection 1's as prescribed by your doctor for effective results. Suprava TZ 562.5 mg Injection 1's may interact with certain tests such as glucose (sugar) in urine and coomb’s test, giving unusual results. Therefore, inform the doctor that you are taking Suprava TZ 562.5 mg Injection 1's before undergoing any tests. If you are on a low-sodium diet or are about to receive calcium-containing products, please inform your doctor before taking Suprava TZ 562.5 mg Injection 1's.
Drug-Drug Interaction: Suprava TZ 562.5 mg Injection 1's may interact with a blood thinner (heparin), drugs used to lower high uric acid levels (probenecid), neuromuscular blocking agent (vecuronium), anticancer drug (methotrexate), water tablet (furosemide) and antibiotics (chloramphenicol, gentamicin, streptomycin).
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: If you have kidney or liver problems, diarrhea, hemolytic anemia (reduction in red blood cells that may cause breathlessness or weakness and make your skin pale yellow), kidney or gall stones, inflammation of the large intestine, inform your doctor before taking Suprava TZ 562.5 mg Injection 1's.
Bacterial infection: It is a condition in which harmful bacteria grow in the body and cause infection. It can target any part of the body and multiply very quickly. Bacteria come in three basic shapes, namely spherical, rod, or spiral-shaped. Bacteria may be gram-positive (have thick cell walls) or gram-negative (do not have cell walls). Appropriate tests are done to identify bacterial strains and based on the results, proper medication is prescribed. Some common symptoms of bacterial infection include cough, fever, and tiredness.
About Suprava TZ 562.5 mg Injection 1's
Suprava TZ 562.5 mg Injection 1's belongs to a class of medication called 'antibiotics' used to treat several bacterial infections of the urinary tract, blood, bones and joints, heart, brain, chest, ears, skin, or soft tissues. A bacterial infection is a condition in which harmful bacteria grow in the body and cause infection. It can infect any part of the body and multiply very quickly. Suprava TZ 562.5 mg Injection 1's does not work against infections caused by the virus.
Suprava TZ 562.5 mg Injection 1's is a combination of two drugs: Ceftriaxone (antibiotic) and Tazobactum (beta-lactamase inhibitor). Ceftriaxone belongs to the class of antibiotics that works by interfering with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damaging the bacterial cell wall and killing bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
You are advised to take Suprava TZ 562.5 mg Injection 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience diarrhea, rash, or abnormalities with white blood cells and platelets. Most of these side effects of Suprava TZ 562.5 mg Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Suprava TZ 562.5 mg Injection 1's, penicillins, or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, please inform your doctor before taking Suprava TZ 562.5 mg Injection 1's. Drive only if you are alert as Suprava TZ 562.5 mg Injection 1's may cause dizziness. You are recommended to complete the full course of Suprava TZ 562.5 mg Injection 1's as prescribed by your doctor for effective results. Suprava TZ 562.5 mg Injection 1's may interact with certain tests such as glucose (sugar) in urine and coomb’s test, giving unusual results. Therefore, inform the doctor that you are taking Suprava TZ 562.5 mg Injection 1's before undergoing any tests.
₹133*
₹113.05*
MRP ₹133
15% CB
₹19.95 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Available Offers
Country of origin
Manufacturer/Marketer address
Suprava TZ 562.5 mg Injection 1's contains Ceftriaxone and Tazobactum. Ceftriaxone is an antibiotic that works by interfering with the formation of the bacterial cell wall (a protective covering) that is necessary for their survival. Thereby damages the bacterial cell wall and kills bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
Suprava TZ 562.5 mg Injection 1's may interfere with urine test (for sugar) and Coomb’s test (blood test) giving false-positive results. Therefore, if you are about to undergo any laboratory tests, inform your doctor or lab technician that you are taking Suprava TZ 562.5 mg Injection 1's.
You are not recommended to take Suprava TZ 562.5 mg Injection 1's with streptomycin as co-administration of these two medicines may increase the risk of kidney damage. However, please consult your doctor before taking Suprava TZ 562.5 mg Injection 1's with other medicines to adjust the dose appropriately.
Suprava TZ 562.5 mg Injection 1's may cause diarrhoea as a common side effect. However, if the condition persists, worsens or notices blood or mucus in stools, avoid taking Suprava TZ 562.5 mg Injection 1's and consult a doctor immediately.
Suprava TZ 562.5 mg Injection 1's is not used to treat viral infections. Suprava TZ 562.5 mg Injection 1's is an antibiotic which is used to treat only bacterial infections.
Suprava TZ 562.5 mg Injection 1's should be used with caution in patients with kidney problems as it may increase the risk of adverse effects. Therefore, inform your doctor if you have any kidney problems before taking Suprava TZ 562.5 mg Injection 1's so that the dose may be adjusted accordingly.
Alcohol
Caution
Interaction of Suprava TZ 562.5 mg Injection 1's with alcohol is unknown. Please consult a doctor before consuming alcohol while using Suprava TZ 562.5 mg Injection 1's.
Pregnancy
Caution
Please consult a doctor if you are pregnant or planning for pregnancy. Suprava TZ 562.5 mg Injection 1's is given to pregnant women only if the doctor thinks benefits outweigh risks.
Breast Feeding
Caution
It is unknown whether Suprava TZ 562.5 mg Injection 1's is excreted in human milk. Suprava TZ 562.5 mg Injection 1's is given to breastfeeding mothers if the doctor thinks benefits are greater than risks. Please consult a doctor if you are breastfeeding.
Driving
Caution
Suprava TZ 562.5 mg Injection 1's may cause dizziness in some people. Therefore, avoid driving if you feel dizzy after taking Suprava TZ 562.5 mg Injection 1's.
Liver
Caution
Take Suprava TZ 562.5 mg Injection 1's with caution, especially if you have a history of Liver diseases/conditions. The dose may be adjusted by your doctor as required.
Kidney
Caution
Take Suprava TZ 562.5 mg Injection 1's with caution, especially if you have a history of Kidney diseases/conditions. The dose may be adjusted by your doctor as required.
Children
Caution
Suprava TZ 562.5 mg Injection 1's is not recommended for premature and new-born babies up to 28 days who has jaundice or certain blood problems. However, Suprava TZ 562.5 mg Injection 1's is given to children only if prescribed by a doctor.
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Uses of Suprava TZ 562.5 mg Injection 1's
Medicinal Benefits
Suprava TZ 562.5 mg Injection 1's is a combination of two drugs: Ceftriaxone (antibiotic) and Tazobactum (beta-lactamase inhibitor) used to treat several bacterial infections. Ceftriaxone is a broad-spectrum antibiotic that acts against both aerobic (grow in the presence of oxygen) and anaerobic (grow in the absence of oxygen) gram-negative and gram-positive bacteria. It interferes with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damages the bacterial cell wall and kills bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
Side Effects of Suprava TZ 562.5 mg Injection 1's
Directions for Use
Storage
Drug Warnings
If you are allergic to Suprava TZ 562.5 mg Injection 1's, penicillins, or any other medicines, please tell your doctor. If you have kidney or liver problems, diarrhea, hemolytic anemia (reduction in red blood cells that may make your skin pale yellow and cause breathlessness or weakness), kidney or gall stones, or inflammation of the large intestine, inform your doctor before taking Suprava TZ 562.5 mg Injection 1's. If you are pregnant or breastfeeding, please inform your doctor before taking Suprava TZ 562.5 mg Injection 1's. Drive only if you are alert as Suprava TZ 562.5 mg Injection 1's may cause dizziness. You are recommended to complete the full course of Suprava TZ 562.5 mg Injection 1's as prescribed by your doctor for effective results. Suprava TZ 562.5 mg Injection 1's may interact with certain tests such as glucose (sugar) in urine and coomb’s test, giving unusual results. Therefore, inform the doctor that you are taking Suprava TZ 562.5 mg Injection 1's before undergoing any tests. If you are on a low-sodium diet or are about to receive calcium-containing products, please inform your doctor before taking Suprava TZ 562.5 mg Injection 1's.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Bacterial infection: It is a condition in which harmful bacteria grow in the body and cause infection. It can target any part of the body and multiply very quickly. Bacteria come in three basic shapes, namely spherical, rod, or spiral-shaped. Bacteria may be gram-positive (have thick cell walls) or gram-negative (do not have cell walls). Appropriate tests are done to identify bacterial strains and based on the results, proper medication is prescribed. Some common symptoms of bacterial infection include cough, fever, and tiredness.
by Others
by Others
by Others
by Others
by Others